Exploring emerging drug responses in Cryptococcus.

Cryptococcus PTMs RNAi drug resistance persistence tolerance

Journal

Trends in microbiology
ISSN: 1878-4380
Titre abrégé: Trends Microbiol
Pays: England
ID NLM: 9310916

Informations de publication

Date de publication:
19 Jul 2024
Historique:
received: 27 03 2024
revised: 23 06 2024
accepted: 02 07 2024
medline: 21 7 2024
pubmed: 21 7 2024
entrez: 20 7 2024
Statut: aheadofprint

Résumé

Cryptococcosis imposes a considerable burden on public health, and emerging drug responses to anticryptococcal drugs remain to be addressed. In this forum article we discuss the emerging drug responses of Cryptococcus, focusing on the critical nature of understanding such responses in order to improve the effectiveness of anticryptococcal therapeutics.

Identifiants

pubmed: 39033069
pii: S0966-842X(24)00172-0
doi: 10.1016/j.tim.2024.07.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests No interests are declared.

Auteurs

Wei Liu (W)

School of Pharmacy, Binzhou Medical University, Yantai, Shandong, China; College of Life and Health Sciences, Northeastern University, Shenyang, China.

Yiru Gao (Y)

College of Life and Health Sciences, Northeastern University, Shenyang, China.

Chen Ding (C)

School of Pharmacy, Binzhou Medical University, Yantai, Shandong, China; College of Life and Health Sciences, Northeastern University, Shenyang, China. Electronic address: dingchen@mail.neu.edu.cn.

Classifications MeSH